| P50 | author | Benedicto Crespo-Facorro | Q49626507 |
| P2093 | author name string | Roberto Roiz-Santiañez | |
| | Paula Suarez-Pinilla | |
| P2860 | cites work | Effects of atypical and typical neuroleptics on anterior cingulate volume in schizophrenia. | Q51925921 |
| | Changes in caudate volume after exposure to atypical neuroleptics in patients with schizophrenia may be sex-dependent. | Q51941974 |
| | Haemodialysis and Cerebral Oedema | Q57384600 |
| | Effect of antipsychotic drugs on cortical thickness. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine | Q57834282 |
| | Brain Volume Changes After Withdrawal of Atypical Antipsychotics in Patients With First-Episode Schizophrenia | Q60610017 |
| | Longitudinal imaging studies in schizophrenia: the relationship between brain morphology and outcome measures. | Q64892735 |
| | Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine | Q72540541 |
| | Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs | Q72692455 |
| | Changes in caudate volume with neuroleptic treatment | Q72824681 |
| | Absence of regional brain volume change in schizophrenia associated with short-term atypical antipsychotic treatment | Q81539112 |
| | Basal ganglia anatomy and schizophrenia: the role of antipsychotic treatment | Q85839759 |
| | Changes in gray matter induced by learning--revisited | Q21562565 |
| | Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress | Q28257571 |
| | The effects of FreeSurfer version, workstation type, and Macintosh operating system version on anatomical volume and cortical thickness measurements | Q30514477 |
| | Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective | Q30581772 |
| | Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? | Q30695945 |
| | Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data | Q31019950 |
| | Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies | Q31043017 |
| | The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics. | Q31657420 |
| | MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: Reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths | Q33411170 |
| | Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings | Q33425487 |
| | Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. | Q33814201 |
| | Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies | Q33860665 |
| | The course of brain abnormalities in schizophrenia: can we slow the progression? | Q33951370 |
| | The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys | Q33985626 |
| | Current status of family intervention science. | Q34306478 |
| | Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia | Q34383654 |
| | Antipsychotic drug effects on brain morphology in first-episode psychosis | Q34408860 |
| | Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies | Q34479485 |
| | Neurogenic actions of atypical antipsychotic drugs and therapeutic implications | Q34662630 |
| | Alcohol use disorders contribute to hippocampal and subcortical shape differences in schizophrenia. | Q35175759 |
| | Longitudinal progression of frontal and temporal lobe changes in schizophrenia | Q36145602 |
| | Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia | Q36395044 |
| | Progression of brain volume changes in adolescent-onset psychosis | Q37100414 |
| | Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects | Q37131066 |
| | Comparison of different methodological implementations of voxel-based morphometry in neurodegenerative disease | Q37336528 |
| | Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study | Q37435199 |
| | Basal ganglia volume in unmedicated patients with schizophrenia is associated with treatment response to antipsychotic medication. | Q37627386 |
| | Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections | Q37706532 |
| | Striatal volume changes in the rat following long-term administration of typical and atypical antipsychotic drugs. | Q42523089 |
| | Acute D2 receptor blockade induces rapid, reversible remodeling in human cortical-striatal circuits | Q43043680 |
| | Hippocampal plasticity in response to exercise in schizophrenia | Q43177651 |
| | Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients | Q43723165 |
| | Prenatal exposure to famine and brain morphology in schizophrenia | Q44036521 |
| | The effect of aerobic exercise on cortical architecture in patients with chronic schizophrenia: a randomized controlled MRI study. | Q44668111 |
| | Follow-up MRI study of the insular cortex in first-episode psychosis and chronic schizophrenia | Q45027787 |
| | Reduced cortical volume and elevated astrocyte density in rats chronically treated with antipsychotic drugs-linking magnetic resonance imaging findings to cellular pathology | Q45039281 |
| | Differential effects of typical and atypical antipsychotics on nerve growth factor and choline acetyltransferase expression in the cortex and nucleus basalis of rats. | Q45068239 |
| | Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia | Q45091258 |
| | Volume changes in gray matter in first-episode neuroleptic-naive schizophrenic patients treated with risperidone | Q45288090 |
| | Three-year longitudinal population-based volumetric MRI study in first-episode schizophrenia spectrum patients. | Q45775101 |
| | Changes in cortical thickness during the course of illness in schizophrenia. | Q45927962 |
| | Effects of eight weeks of atypical antipsychotic treatment on middle frontal thickness in drug-naïve first-episode psychosis patients | Q46235270 |
| | Volumetric MRI measurement of caudate nuclei in antipsychotic-naive patients suffering from a first episode of psychosis | Q46416782 |
| | Cerebral cortical gray expansion associated with two second-generation antipsychotics | Q46578655 |
| | Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia | Q46693287 |
| | Progressive brain volume loss during adolescence in childhood-onset schizophrenia | Q47364106 |
| | Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: relationship to dose and symptoms | Q48093284 |
| | Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood | Q48122360 |
| | Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics | Q48134165 |
| | Olanzapine increases grey and white matter volumes in the caudate nucleus of patients with schizophrenia | Q48143027 |
| | Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug | Q48242740 |
| | Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study | Q48258798 |
| | Cigarette smoking and progressive brain volume loss in schizophrenia | Q48273078 |
| | Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. | Q48286419 |
| | Brain volume changes in first-episode schizophrenia: a 1-year follow-up study | Q48452819 |
| | Caudate volume changes in first episode psychosis parallel the effects of normal aging: a 5-year follow-up study | Q48457038 |
| | Brain structural changes associated with chronicity and antipsychotic treatment in schizophrenia | Q48472115 |
| | A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures | Q48519543 |
| | Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer | Q48559315 |
| | Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain | Q48605550 |
| | Progressive brain changes in children and adolescents with first-episode psychosis | Q48731809 |
| | Volume increases in striatum associated with positive symptom reduction in schizophrenia: a preliminary observation | Q48759663 |
| | Magnetic resonance imaging signatures of tissue pathology in frontotemporal dementia | Q48770348 |
| | A serial longitudinal quantitative MRI study of cerebral changes in first-episode schizophrenia using image segmentation and subvoxel registration. | Q48913191 |
| | Ten year progressive ventricular enlargement in schizophrenia: an MRI morphometrical study | Q48962151 |
| | Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment | Q49048938 |
| | One year longitudinal study of the straight gyrus morphometry in first-episode schizophrenia-spectrum patients | Q49200217 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | brain | Q1073 |
| | nervous system | Q9404 |
| | schizophrenia | Q41112 |
| | magnetic resonance imaging | Q161238 |
| | antipsychotics | Q208144 |
| | systematic review | Q1504425 |
| | biomedical investigative technique | Q66648976 |
| P304 | page(s) | 422-34 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Current Neuropharmacology | Q20181354 |
| P1476 | title | Brain Structural Effects of Antipsychotic Treatment in Schizophrenia: A Systematic Review | |
| P478 | volume | 13 | |